![]() |
市場調查報告書
商品編碼
2046464
子宮內監測設備市場-全球產業規模、佔有率、趨勢、機會、預測:按產品類型、最終用戶、地區和競爭對手分類,2021-2031年Intrapartum Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Electrodes, Monitors), By End User (Hospitals, Maternity Centers, Others), By Region & Competition, 2021-2031F |
||||||
全球分娩監測設備市場預計將大幅擴張,從 2025 年的 17.8 億美元成長到 2031 年的 28.1 億美元,複合年成長率為 7.91%。
這些重要的診斷工具旨在持續監測分娩過程中胎兒的心率和子宮收縮情況,從而能夠及時發現胎兒異常和潛在併發症。該市場的持續成長主要得益於全球高風險懷孕數量的增加、非侵入性監測技術的不斷進步,以及透過密切的即時監測降低孕產婦和新生兒死亡率的合作努力。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 17.8億美元 |
| 市場規模:2031年 | 28.1億美元 |
| 複合年成長率:2026-2031年 | 7.91% |
| 成長最快的細分市場 | 醫院 |
| 最大的市場 | 北美洲 |
監測解決方案的創新正在進一步提升患者的活動能力和舒適度,從而促進其更廣泛的應用。例如,根據美國早產兒基金會(March of Dimes)2024年的數據顯示,美國約有38萬例早產兒,凸顯了對有效胎兒監測技術的迫切需求。然而,市場仍存在諸多障礙,包括嚴格的法規結構,這可能會延緩新設備的核准和商業化。此外,先進監測系統的高成本限制了其在低收入醫療機構的應用,這可能會阻礙發展中地區的整體市場成長。
早產和高風險懷孕的增加是全球圍產期監護設備市場的主要促進因素,也因此對持續監護以預防不良妊娠結局的需求日益迫切。臨床醫生越來越依賴先進的診斷技術來處理複雜的產程,這些產程通常與高齡生產、肥胖和先前手術史等因素有關。這種日益成長的依賴性體現在剖腹產率的上升,使得細緻的即時胎兒監護對於確保患者安全至關重要。根據美國疾病管制與預防中心 (CDC) 於 2025 年 7 月發布的《2024 年美國出生情形》報告,美國首次剖腹產率將達到 22.9%,這表明分娩管理的複雜性日益增加。持續更新的早產統計數據進一步凸顯了這個迫切的臨床需求。根據美國早產兒基金會(March of Dimes)的報告,到 2025 年,美國的早產率將達到全國 10.4%,凸顯了強大的監測解決方案在高風險產科環境中發揮的關鍵作用。
同時,非侵入性無線監測系統的技術進步顯著推動了市場擴張,克服了傳統有線感測器的固有限制。遙測和訊號處理技術的創新使孕婦在分娩過程中擁有更大的活動自由度,促進生理進程,同時確保臨床數據的完整性。這些無線解決方案正迅速部署到各大醫院網路中,旨在實現產科現代化,在不影響訊號準確性的前提下提升病患舒適度。一個顯著的例子是皇家飛利浦公司於2025年2月發布的「2024年第四季及全年財務表現」。該公司旗下包含病患監測的互聯護理業務部門報告稱,第四季度同店銷售額成長了7%。這項需求成長清晰地表明,整個產業正在向整合化、高度行動化的平台轉型,以兼顧臨床效率和改善分娩體驗。
先進分娩監護系統的高昂成本是其廣泛應用的主要障礙,直接限制了全球市場的成長。醫療機構,尤其是那些在資源匱乏環境下運作的機構,常常難以籌措購買這些高價值診斷技術所需的資金。當醫療機構優先考慮短期營運成本而非巨額資本投資時,最新監護設備的引進往往會被推遲。這種財務壓力迫使醫療服務提供者繼續使用過時的設備,而不是採用更新、更先進的非侵入式解決方案,最終導致製造商的總銷售額下降。
推遲投資的趨勢源自於近期產業數據,這些數據凸顯了醫療機構面臨的嚴峻財務挑戰。美國醫院協會 (AHA) 在 2025 年報告中估計,94% 的醫療機構管理者預計將推遲設備升級,以應對日益沉重的財務負擔。如此高的採購延遲率表明,即使先進的監測技術已經問世,經濟上的限制也有效地阻礙了其在日常臨床實踐中的應用。因此,市場呈現銷售週期延長和採用率下降的趨勢。這主要是因為對於相當一部分醫療機構而言,採用高價值的監測設備在經濟上仍然不可行。
自動胎心監護(CTG)分析系統的出現,有效解決了胎心心率圖分析中觀察者間差異這一重大挑戰,正迅速改變市場格局。醫療機構正擴大採用這些演算法解決方案,以規範臨床決策並提高安全性,尤其是在高風險分娩中。與易受人為錯誤和疲勞影響的傳統人工評估不同,這些自動化系統能夠客觀、持續地分析胎兒訊號,從而在複雜病例中實現早期療育。這種朝向更廣泛的電腦輔助監測的策略轉變,源自於產業為保護更脆弱的病患小組所做的努力。例如,2025年2月,PeriGen宣布其人工智慧驅動的胎兒監護系統已獲得FDA批准,可用於分析妊娠32週的胎心率模式。這顯著擴大了早產管理的安全保障範圍。
同時,人工智慧 (AI) 在即時風險評估中的應用正積極推動市場成長,其最佳化臨床工作流程和減輕產科人員的工作量是關鍵所在。除了基本的訊號追蹤之外,先進的 AI 技術現已直接整合到診斷平台中,能夠自動完成複雜的測量,並在分娩分診過程中改善解剖結構的可視化效果。這項技術進步使臨床醫生能夠更快、更準確地獲得關鍵的生理數據,這在時間緊迫的分娩緊急情況下尤其重要。這些以提高效率為導向的創新所帶來的顯著影響顯而易見。 GE 醫療於 2025 年 1 月發布的 AI 增強型女性健康超音波系統 SonoPelvicFloor 3.0,可將骨盆底測量時間縮短高達 80%,充分展現了 AI主導的自動化如何最佳化產科評估的速度和準確性。
The Global Intrapartum Monitoring Devices Market is set for substantial expansion, with projections indicating growth from USD 1.78 Billion in 2025 to USD 2.81 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 7.91%. These essential diagnostic tools are designed to continuously track fetal heart rate and uterine activity during labor, enabling timely identification of distress and potential complications. The market's consistent growth is primarily fueled by a rising global incidence of high-risk pregnancies and a concerted effort to mitigate maternal and neonatal mortality through vigilant real-time surveillance, alongside ongoing technological advancements in non-invasive monitoring.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.78 Billion |
| Market Size 2031 | USD 2.81 Billion |
| CAGR 2026-2031 | 7.91% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
Innovations in monitoring solutions further enhance patient mobility and comfort, contributing to their broader adoption. For instance, data from the March of Dimes in 2024 revealed that approximately 380,000 preterm births occurred in the United States, underscoring the critical and ongoing need for effective labor monitoring technologies. However, the market faces significant hurdles, including stringent regulatory frameworks that can delay new device approvals and commercialization. Additionally, the high cost of advanced monitoring systems limits their uptake in lower-income healthcare settings, thereby potentially restricting overall market expansion in developing regions.
Market Driver
The increasing occurrence of preterm births and high-risk pregnancies represents a primary driver for the Global Intrapartum Monitoring Devices Market, creating a critical demand for continuous surveillance to prevent adverse outcomes. Clinicians are increasingly dependent on sophisticated diagnostic technologies to manage complex deliveries, which are often associated with factors such as advanced maternal age, obesity, and prior surgical interventions. This growing reliance is reflected in the rising rate of operative deliveries, necessitating vigilant real-time fetal tracking to ensure patient safety. According to the Centers for Disease Control and Prevention's July 2025 'Births in the United States, 2024' report, the primary cesarean delivery rate in the U.S. climbed to 22.9%, illustrating the escalating complexity of labor management. This intense clinical need is further emphasized by persistent statistics on prematurity, with the March of Dimes reporting a national preterm birth rate of 10.4% in the United States in 2025, highlighting the essential role of robust monitoring solutions in high-risk obstetric environments.
Concurrently, technological advancements in non-invasive and wireless monitoring systems are significantly propelling market expansion by overcoming the inherent limitations of traditional cabled sensors. Innovations in telemetry and signal processing now offer expectant mothers enhanced freedom of movement during labor, which can facilitate physiological progress while maintaining the integrity of clinical data. These wireless solutions are experiencing rapid adoption within hospital networks aiming to modernize their obstetrics departments, thereby improving patient comfort without compromising signal accuracy. A notable example is Koninklijke Philips N.V.'s 'Fourth Quarter and Annual Results 2024' from February 2025, where its Connected Care business segment, which includes patient monitoring, reported a 7% increase in comparable sales for the fourth quarter. This uptake clearly demonstrates the industry-wide transition towards integrated, mobility-enhancing platforms that support both clinical efficiency and an improved birthing experience.
Market Challenge
The substantial cost associated with advanced intrapartum monitoring systems stands as a significant impediment to their widespread adoption, thereby directly constraining the growth of the global market. Healthcare facilities, particularly those operating in environments with limited resources, frequently struggle to allocate the necessary capital for these high-value diagnostic technologies. When institutions prioritize immediate operational expenditures over substantial capital investments, the acquisition of modern monitoring units is often deferred. This financial pressure compels providers to continue using older equipment instead of procuring newer, more advanced non-invasive solutions, consequently diminishing overall sales volumes for manufacturers.
This pattern of delayed investment is corroborated by recent industry data that underscores the severe fiscal challenges confronting healthcare providers. The American Hospital Association reported in 2025 that an estimated 94% of healthcare administrators anticipated postponing equipment upgrades to manage escalating financial strains. Such a high proportion of deferred purchases indicates that even when superior monitoring capabilities become available, economic constraints effectively prevent their integration into routine clinical practice. As a result, the market experiences extended sales cycles and reduced penetration rates, largely because the economic feasibility of acquiring high-value monitoring devices remains out of reach for a considerable segment of the healthcare sector.
Market Trends
The emergence of Automated Cardiotocography (CTG) Interpretation Systems is swiftly transforming the market by effectively addressing the critical issue of inter-observer variability in the analysis of fetal heart rate traces. Healthcare providers are increasingly incorporating these algorithmic solutions to standardize clinical decision-making and enhance safety, particularly in high-risk deliveries. Unlike traditional manual interpretation, which is susceptible to human error and fatigue, these automated systems offer objective, continuous analysis of fetal signals, facilitating earlier intervention in complex cases. This strategic shift towards expanded computational surveillance is evidenced by the industry's drive to protect more vulnerable patient groups. For example, PeriGen announced in February 2025 that its AI-Powered Fetal Monitoring System received FDA clearance to analyze fetal heart rate patterns for fetuses as young as 32 weeks gestation, significantly expanding the safety net for preterm labor management.
Simultaneously, the integration of Artificial Intelligence (AI) for real-time risk assessment is actively driving market growth by optimizing clinical workflows and alleviating the operational burden on obstetric staff. Beyond basic signal tracking, advanced AI is now embedded directly into diagnostic platforms to automate complex measurements and enhance anatomical visualization during labor and delivery triage. This technological evolution enables clinicians to acquire critical physiological data with greater speed and consistency, which is particularly vital during time-sensitive intrapartum emergencies. The profound impact of such efficiency-focused innovation is clear: GE HealthCare's January 2025 announcement of its AI-Enhanced Women's Health Ultrasound System, featuring the SonoPelvicFloor 3.0, demonstrated an ability to reduce pelvic floor measurement exam time by up to 80%, showcasing how AI-driven automation successfully optimizes the speed and accuracy of obstetric assessments.
Report Scope
In this report, the Global Intrapartum Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Intrapartum Monitoring Devices Market.
Global Intrapartum Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: